Edition:
United Kingdom

People: Audentes Therapeutics Inc (BOLD.OQ)

BOLD.OQ on NASDAQ Stock Exchange Global Market

39.14USD
23 Jul 2019
Change (% chg)

-- (--)
Prev Close
$39.14
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
154,936
52-wk High
$42.04
52-wk Low
$18.00

Patterson, Matthew 

Mr. Matthew R. Patterson is Chairman of the Board, Chief Executive Officer of the Company. Prior to Audentes, Mr. Patterson was an Entrepreneur-In-Residence at OrbiMed, and previously worked at Amicus Therapeutics, Inc., BioMarin Pharmaceutical Inc. and Genzyme Corporation. Mr. Patterson currently serves as Chairman of the Alliance for Regenerative Medicine (ARM), the international advocacy organization representing the gene and cell therapy and broader regenerative medicine sector. He is a member of the Board of Directors for Homology Medicines, Inc. and Modis Therapeutics, Inc. Mr. Patterson received his B.A. in Biochemistry from Bowdoin College. Our board of directors believes that Mr. Patterson should serve as a director due to the perspective he brings as our founder and his expertise in the fields of business, biotechnology and drug development.

Basic Compensation

Total Annual Compensation, USD 542,000
Restricted Stock Award, USD --
Long-Term Incentive Plans, USD --
All Other, USD 238,480
Fiscal Year Total, USD 780,480

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised 181,000 6,219,950.00